Category: Leading-Pharmaceutical-Companies-Profiles

Today, India has become the largest provider of generic drugs on the global level after supplying more than 50 percent of global demand for various vaccines, 40 percent of generic demand in the US and 25 percent of all medicines in the UK. The pharmaceutical market has become the largest exporter of medication by volume. In terms of market size, the Indian pharma industry is expected to grow over 15 percent per annum during the same period. The market is expected to progress to US$55 billion by 2020, thereby emerging as the sixth-largest pharmaceutical market globally by its size.

But 2019 ended on a sour note for Indian pharmaceutical companies, with the Nifty Pharma index down about 10% so far. When it is compared with the Nifty 50 index has risen about 10%. And, unfortunately, the pharmaceutical firms may not be out of the woods in 2020. The US FDA inspections increased considerably in 2019 and led to the Indian drug makers getting about 23 warning letters. Today, Indian companies account for about one official action-indicated letter. Indian companies account for about one official action-indicated letter for every six inspections that are worrisome.

Most pharma stocks that got observation letters, OAI letters, or warning letters went into a tailspin. As the US FDA inspects over 400 manufacturing plants in the country every two years, the risk of adverse observations remains high.

Here what could be the solution? Its control over costs, with the added element of curtailing capacity expansion. It would boost the return on equity in the long run. Still, some critical risks for domestic pharma could come from issues like NLEM and price controls. In our country, drugs are assumed as expensive, but any move to review costs could severely eat into the margins of pharma companies. The domestic pharma market has been progressing at a rapid pace that aided profitability enhancements. If domestic pricing pressure increases, margins and profitability could be eroded.

A good thing is that the earnings downgrade cycle has moderated. This time, although, the market is factoring in higher potential earnings growth for 2020. Give the heavy and looming overhangs, as high earnings growth could be at a risk. If the actual progress rate contracts, the Indian pharmaceutical industry of India could still be in for topsy-turvy 2020.

Road Ahead

Medicine spending of the country is projected to grow 9-12 percent in the next five years, leading India to become one of the top 10 countries in terms of medical spending.

Going forward, better growth in domestic sales would also depend on the ability of companies to align their product portfolio towards the chronic therapies for diseases like cardiovascular, anti-diabetes, anti-depressants and anti-cancers, which are on the rise. The government has taken steps to cut costs and reduce the expenses of healthcare. Speedy introduction of generic drugs in the market has remained in focus and is expected to support the Indian pharmaceutical companies to gain profit.

India is on the leading position in the generic drugs market globally and is the largest provider of the same across the world. Indian pharmaceutical industry manufacturers over 50 percent of the global medicine including 40 percent demand in the US and 25 percent of all demand in the UK.

Top Pharma companies in India are generating effective formulations to meet the increasing demand for pharmaceutical products across Indian and the world.

Medicines had been through a lot of innovation in the past few years and with every step, they have grown. Many new companies have emerged well with their innovation, development, and contribution to healthy mankind. The pharmaceutical industry is now experiencing the wave of these emerging top Pharma Companies in India which are flourishing at a faster rate with their innovative solutions.

In this article, we have summed up some of the best Indian pharma companies which offer quality products at an affordable range. Besides, these companies hold brand value and market reach;

Sun Pharma

Sun Pharma is one of the top pharma companies in India; it was founded by Dilip Shanghvi in the year 1983. The firm recorded more than 72 percent of its sales from overseas market, mainly in the US, accounting for above 50 percent of its turnover. It has manufacturing units set up in different companies including México, Brazil, US, Canada, and Israel.

Cipla

Headquartered in Mumbai, Cipla is known for developing medicines to treat respiratory, arthritis, diabetes, cardiovascular disease, weight control, depression, and many other medical conditions. The company holds 34 manufacturing units in 8 locations across the country.

Aurobindo Pharma Ltd

Founded in the year 1986, Aurobindo Pharma Ltd is a leading pharmaceutical company manufactures anti allergies, antibiotics, gastroenterological, central nervous system products and cardiovascular products. The firm is involved in a range of products including formulation, pharmaceutical ingredients, and organic intermediates.

DM Pharma Marketing Pvt Ltd

One of the leading pharmaceutical companies in India, DM Pharma offered medicines that are capable of treating the most difficult health issues. Over the years, the company has grown to the leading name in the industry with its impeccable contribution towards the healthcare sector.

L. Healthcare

A famous and trusted name in the pharma industry, H. L. Healthcare has been involved in the manufacturing supply, trading and franchise business for a long time. The firm works with the motive to prevent, diagnose, alleviate and cure diseases. H. L. Healthcare delivers an exceptionally well and highly effective range of drugs.

Apikos Pharma

Chandigarh based Pharma Company; Apikos Pharma has made into the list of top pharma companies in India because of its rapid growth. The firm is known for providing world-class Pharma formulation and also deals with the research and invention of new pharma products for several health-related issues.

Glenmark Pharmaceuticals Ltd

Among the leading pharmaceutical companies in India, Glenmark Pharmaceuticals is a famous name. It was founded in 1977 by Gracias Saldenha. Its product range includes vaccines and medicines. Initially, the firm sold its products in India, Africa, and Russia and is now dealing all across the world.

So these are the leading names in India pharmaceutical. We hope you enjoy the article.  If  you want to add any name, please let us know.

Gaining prominence in recent years, the pharmaceutical products industry of India has turned into a sunrise sector and has served as a significant connection between the industrial and the chemical segments of the economy.

Since its inception, the lanolin manufacturing company, Rolex Lanolin Products Limited (RLPL) has strived to penetrate newer areas of technology and business. The specialty company was established in 1967, and is headquartered in Mumbai. Itserves severalof its customers(many being in the pharmaceutical sector) with its differentiated lanolin products.

RLPL is certified under ISO 9001:2008 (QMS); ISO 14001:2004 (EMS); BS 18001:2007 (OHSAS) and EFfCI (cGMP) supported by an excellent team of professionals, led by highly experienced leaders,and a state-of-the-art manufacturing + R&D facilities. The firm has made rapid strides over the years and is supposedly the undisputed market leader today known for supplying high quality products. RLPL is also an Govt Recognised Export House, AEO Registered and its products meet/exceed practically all national and international standards.

Uncompromising insistence on high-quality standards, continuous innovation and the conscious commitment and dedication to providing value for money to the customer have made RLPL a renowned name.

THE MEN BEHIND RLPL &THEIR BRANDS

Hasmukh N. Zaveri, Founder & Chairman, RLPL, is a visionary having introduced LANOLIN to India the very first time in mid-sixties. His son Hasit Zaveri, versatile and ambitious, has been instrumental in the company’s growth and expansion and joined his father in the mid-eighties and is the current Managing Director of the company. They have extensive experience and industry knowledge.

With their excellent guidance and dynamic leadership, Jash Zaveri (the third generation who joined the family business in 2017 after completing his Masters from London Business School) is now focused on taking RLPL to a higher plane.

JOURNEY SINCE INCEPTION

Rolex Lanolin Products Limited was formed in 1967 under the aegis of Hasmukh N. Zaveri with a small manufacturing plant in the Tardeo area of Mumbai and its first office in Princess Street – the Heart of Mumbai’s Chemical market. In 1971 Rolex set up a larger plant as a Registered Small-Scale Industry Unit at Andheri. It was here that the commercial production of Lanolin commenced successfully.

In 2015, RLPL successfully shifted its manufacturing facilities to a new state-of-the-art plant at Vapi, Gujarat. The facility is spread over 6972 square meters with an enhanced licensed capacity and an in-house laboratory facility for Quality Control and Assurance.

DIFFERENT PRODUCTS AND SERVICES

From offering just 3 grades of Lanolin in the early ’80s, RLPL offers over 50 grades today. Research & Development has always been crucial to their operations and success. They have successfully developed many customized specifications as per their clients’ specific requirements using different methodology but maintaining the key features and characteristics of Lanolin. The new in-house R&D facility (opened in February 2019), Woolfat Research Centre (WRC), is a 100% owned subsidiary of RLPL. WRC offers services for the development of various Lanolin based blends and formulations for cosmetics, topical pharmaceuticals, industrial, and household products.

AWARDS, ACHIEVEMENTS, AND RECOGNITIONS

RLPL’s success in developing Lanolin indigenously and commercially manufacturing the same strictly to the Indian Pharmacopoeia standards for the first time in India won it the appreciation from the “The Invention Promotion Board” of the Central Govt. sponsored National Research & Development Corporation. They were thus presented in 1974 with a coveted Bronze Import Substitution Award and Certificate of Merit by the then honourable Union Minister for Commerce and Industry of India. Their further success in developing Lanolin as a Cosmetic Intermediate won them the appreciation from the Federation of Associations of Small-Scale Industries of India (F.A.S.I.I.), and were presented in 1984 with the A. R. Bhatt Entrepreneurship Award by the honourable Vice President of India. In 2004, RLPL received the Bombay Industries Association’s (B.I.A.) Excellence Award. Rolex Lanolin completed 50 years in the Lanolin business in 2017 and has over fifty various products to offer, as well as over 500 clients across the world including PSU’s, MNC’s and leading FMCG companies. Today Rolex Lanolin is compliant with various internationally acceptable standards and accreditations.

WHAT IS LANOLIN?

Lanolin is a key ingredient used in topical pharmaceutical, cosmeceutical, cosmetic, personal care and skincare products. It is a natural waxy substance that is derived from sheep’s wool. Lanolin and its derivatives are a one-stop solution for skin problems. It is the ultimate emollient, emulsifier, stabilizer and moisturizer. In the case of dry skin and psoriasis, it forms a film on the skin that limits water loss across the skin surface whereas ingredients such as petroleum jelly moisturize by retarding the evaporation of water.

With its legacy dating back to 1951, Indian Herbs Specialities Pvt Ltd. remains at the very forefront of the world of animal healthcare with its market-leading products, multiple awards and a commitment towards better health care and productivity enhancement of animals.

Creating a benchmark of quality, safety, and efficacy, Indian Herbs sets the standards for herbal veterinary products that others only struggle to achieve. It holds depots in every state and UT, separate field force for livestock, poultry and aqua fields, more than 750 stockists and 15,000 veterinary retail outlets throughout the length and breadth of the country.

Besides being a top herbal AHP company in India, Indian Herbs’ products are also exported to more
than 50 countries. Though China holds No.1 position in the world market of herbal human health care products, the distinguished work of present Chairman and CEO of Indian Herbs, Sushiel Agrawal, has put India on No.1 position as a pioneer in the world market of herbal veterinary products.

FOUNDATION WITH GLOBAL GROWTH POTENTIAL

Around independence in 1947, the animals were not treated well, as all allopathic veterinary medicines were being imported, they were expensive and not easily available. Shri Ram Lal Agrawal, a freedom fighter decided to develop herbal medicines for animals and founded Indian Herbs in 1951.

Dr. Sushiel Agrawal, the current Chairman and CEO of Indian Herbs joined his father’s business in 1968 and gave practical shape to the concept of Veterinary Ayurveda, on modern scientific lines including pharmacological, toxicological and controlled clinical studies.

As better and economical alternatives to imported vitamins and amino acids, Sushiel Agrawal succeeded in developing Natural Vitamin C, E, Choline as well as methionine and lysine etc.

As per ORG veterinary market survey reports, Indian Herbs achieved 4th ranking in 1992 overtaking leading Veterinary companies.

SERVICE PORTFOLIO

Indian Herbs offers a wide range of more than 200 herbal Medicines and nutritional products for livestock, poultry, canines, equines and aquaculture. Since 1998, Indian Herbs is also engaged in research, development and manufacturing of unique Ayurmed Specialities (Human Herbal Medicines), particularly for those therapeutic segments where modern system of medicine does not provide satisfactory cures.

DISTINGUISHING FACTORS

• A well-equipped modern R&D Centre recognized by Ministry of Science, Govt. of India.
• Developed suitable Methods of Analysis and Standardisation for Herbal Veterinary Products based on finger printing, using chromato graphic techniques.
• Besides clinical studies, advanced scientific studies like Cell Culture Studies, Nutrigenomic, Metagenomic Profiling, Morphometry, Histo chemistry and Histomorphology Studies, Digestibility and Metabolic Modulation Studies, Profiling by ELISA etc., on the products.
• Over 200 Veterinary Scientists have been awarded higher degrees such as Ph.D., M.V.Sc. for conducting research on Indian Herbs products.
• More than 1000 research papers published on Indian Herbs’ products.
• Many quality certifications like GMP, GMPPlus, ISO 9001:2015, OHSAS 18001:2007, HACCP, FSSAI.
• 22 Patents including a unique drug delivery system.

THE MAN BEHIND VISION

Sushiel Agrawal, the present CEO of the company was the first to introduce the concept of herbal growth promoters in Poultry and Livestock in place of hormones, steroids, antibiotics etc. Sushiel Agrawal has so far personally authored 53 research papers published in eminent journals and magazines.

Sushiel Agrawal presented the science of Veterinary Ayurveda at many Conventions and Seminars of Veterinary Scientists, Consultants, Nutritionists and Farmers in India and around 50 countries of the
world.

Indian Herbs products have been approved for organic farming in EEC etc. Sushiel Agrawal was invited as Guest Speaker at First International Conference for Organic Animal Farming in USA in 2006.

He was a panel member in a TV programme organized by Doordarshan in the late 90s on the use of herbal veterinary products for health care of pets and domestic animals. Appreciating the concept of Veterinary Ayurveda, BBC telecast the programmes on `Country Watch’ and ‘Country File’ programmes in 1994.

JEWELS IN THE CROWN

National Awards for: Outstanding Entrepreneurship (2007), Outstanding R&D achievements (2008), Outstanding Quality Products (2010), Business Innovation (2014-15) by Ministry of MSMEs, Govt. of India as well as State Awards for Export Excellence (1995-96 to 2018-19) and Product Quality Excellence (2009-10) from Govt. of U.P.

AIMA – Dr. J.S. Juneja Award for creativity and innovation in SMEs with cash prize by All Indian Management Association, Delhi in 2007.

The National Academy of Veterinary Sciences (India), New Delhi conferred Hony. Fellowship to Sushiel Agrawal in 2012.

Indian Federation of Animal Health Companies, Mumbai presented INFAH Award 2017 to Sushiel Agrawal.

Maintaining No.1 position in herbal AHP market in India since 1951, Indian Herbs is the first company to receive approval from the Export Inspection Council of India and Status of 2 Star Export House from the Ministry of Commerce & Industry, Govt. of India.

CURRENT SCENARIO

There is increasing interest in herbal (natural) products for use in animals due to the side effects, withdrawal problems, residual toxicity, resistance development and undesirable consequences associated with synthetic and chemical products.

MAJOR CHALLENGES AND OPPORTUNITIES

The natural products need to be scientifically developed with clearly defined modes of action, rigid standardisation and quality control. Consumers of milk, meat and eggs are now more aware and look for healthy and nutritious foods, free from use of pesticides, antibiotic growth promoters and other chemical products.

HICCUPS ON THE WAY

In the B.V.Sc. curriculum of Veterinary Colleges, only Allopathic Veterinary Medicines were taught. Therefore, Indian Herbs had to make extra efforts to educate the Veterinary Practitioners about the products.

When the products of Indian Herbs became popular, unscrupulous companies ventured into this field,
without any scientific backup, on the basis of low prices, without caring for quality and efficacy. This caused damage to image and credibility of herbal products for some time.

MNCs lobbied that herbal products are not scientific. Indian Herbs had to invest a lot to arrange extensive clinical trials in comparison to allopathic and other herbal veterinary products to prove the efficacy, safety and justify the prices of the products.

CORPORATE ETHOS FOR CUSTOMERS

Indian Herbs provides the right products with dependable quality, efficacy and safety, which helps to gain the trust and confidence of customers. They seek suggestions from distributors and users for the development of new products required by them and improvement in the existing products and the services.

ROAD AHEAD

Because of the increasing trust in Indian Herbs’ products, the market share is regularly increasing both in India and the international market. It is increasingly felt that the future will belong to medicines and health foods based on natural products and Indian Herbs is fully equipped to meet these requirements.

GUIDING FORCE

• Shri Sudhakar Agarwal- Director(Production)
• Shri Gaurav Agrawal- Director (Marketing)
• Shri Vipul Agrawal- Director (Finance)